Daily non-political popular news in brief.

DAYTRANA (methylphenidate transdermal system) provides individualized ADHD symptom management

Shire's Attention Deficit Hyperactivity Disorder patch, DAYTRANA tm (methylphenidate transdermal system) has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when removed earlier than the recommended nine hours. The ability to remove the patch earlier allows physicians the opportunity to manage potential late-day side effects, such as lack of appetite or difficulty sleeping, according to phase 3b trial results reported at a scientific child and adolescent psychiatry meeting in San Diego.

Read more »

Keywords: daytrana, methylphenidate, transdermal, system, provides, individualized, adhd, symptom, management, provide

« Previous | Next »

Similar news on "DAYTRANA (methylphenidate transdermal system) provides individualized ADHD symptom management":

1. Long-term 12-month safety data on ADHD patch DAYTRANA
   10-25-2007 · EurekAlert!
   Shire plc announced that DAYTRANA (methylphenidate transdermal system), the ADHD patch, provided significant ADHD tolerability and symptom control improvement in children aged 6 to 12 years, according to data from a 12-month study presented today at a major scientific and educational meeting of child and adolescent psychiatrists.
   Similar news · Read more »
   
2. New study of Concerta showed significant improvement of ADHD symptom management in adults
   10-26-2007 · EurekAlert!
   Adults with ADHD treated with CONCERTA OROS methylphenidate HCl extended-release tablets showed significant improvements in ADHD symptom management compared to adults taking placebo, according to study results presented today at a major psychiatric medical meeting.
   Similar news · Read more »
   
3. SIV infection of natural hosts provides new insights into HIV disease complexity
   09-06-2007 · EurekAlert!
   Three related papers published in the Sept. 1 edition of the Journal of Immunology provide key new insights into the complexity of HIV/AIDS. Don Sodora, Ph.D., a principal investigator in SBRI's Viral Vaccines Program who recently joined SBRI from the University of Texas, Southwestern Medical Center, is senior author on one of three papers that collectively show CD4 T-cell depletion, a critical symptom of AIDS, is likely a part of a multifaceted scenario that triggers disease rather than the only cause.
   Similar news · Read more »
   
4. 12-month study demonstrated tolerability and efficacy of Daytrana
   05-23-2007 · EurekAlert!
   Shire plc announced that Daytrana, the first and only non-oral medication approved for treatment of ADHD in children aged 6 to 12 years, provided significant improvement in symptom control and tolerability, according to results of a 12-month open-label study presented at the American Psychiatric Association annual meeting.
   Similar news · Read more »
   
5. Daytrana provides significant effectiveness in both boys and girls with ADHD
   05-23-2007 · EurekAlert!
   Shire plc announced that DAYTRANA, its ADHD patch medication, had significant efficacy in reducing the symptoms of ADHD in both male and female children aged 6 to 12 years, according to clinical trial results reported at the American Psychiatric Association annual meeting. Few clinical studies have examined gender differences in the response to ADHD treatments.
   Similar news · Read more »
   
6. Virginia Tech's System X supercomputer provides super tool for simulation of cell division
   01-30-2007 · EurekAlert!
   Virginia Tech researchers in computer science and biology have used the university's supercomputer, System X, to create models and algorithms that make it possible to simulate the cell cycle -- the processes leading to cell division. They have demonstrated that the new mathematical models and numerical algorithms provide powerful tools for studying the complex processes going on inside living cells.
   Similar news · Read more »
   
7. Preschoolers with ADHD improve with low doses of medication
   10-16-2006 · EurekAlert!
   The first long-term, large-scale study designed to determine the safety and effectiveness of treating preschoolers who have attention deficit/hyperactivity disorder with methylphenidate has found that overall, low doses of this medication are effective and safe. However, the study found that children this age are more sensitive than older children to the medication's side effects and therefore should be closely monitored.
   Similar news · Read more »
   
8. 18F-DG PET/CT can highly increase the detection of colorectal cancer
   10-10-2007 · EurekAlert!
   Colorectal cancer is currently the most common gastrointestinal malignancy. Recurrence and/or metastasis occurs in 30 to 50 percent of patients after surgery. Early diagnosis and accurate staging of postoperative recurrence and metastasis is crucial for prescribing an optimal, individualized treatment plan. Research performed in China by Dr. Chen has found that combined positron emission tomography and computed tomography can provide complete information about the location, nature and extent of lesions.
   Similar news · Read more »
   
9. Sports concussion research using fMRI provides insight for safe return-to-play decisions
   08-06-2007 · EurekAlert!
   Concussions are common in young athletes but the underlying changes in brain function that occur have been poorly understood. Now, a University of Pittsburgh study is the first to link changes in brain function directly to the recovery of the athlete. The study results confirm that changes in brain function seen on fMRI may be reliably measured by neuropsychological testing, a tool commonly used nationwide by team doctors in making critical decisions about safe concussion management.
   Similar news · Read more »
   
10. Penn researchers provide insights into how the immune system avoids attacking itself
    10-12-2006 · EurekAlert!
    A finding by University of Pennsylvania School of Medicine researchers about how immune cells "decide" to become active or inactive may have applications in fighting cancerous tumors, autoimmune diseases and organ transplant rejection. They found that small fatty acids called diacylglycerols, and the enzymes that metabolize them, are critical players in the molecular pathway that leads to activity versus inactivity.
    Similar news · Read more »